These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15369697)

  • 1. Salvinorin A: a novel and highly selective kappa-opioid receptor agonist.
    Yan F; Roth BL
    Life Sci; 2004 Oct; 75(22):2615-9. PubMed ID: 15369697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptor.
    Sheffler DJ; Roth BL
    Trends Pharmacol Sci; 2003 Mar; 24(3):107-9. PubMed ID: 12628350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
    Roth BL; Baner K; Westkaemper R; Siebert D; Rice KC; Steinberg S; Ernsberger P; Rothman RB
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11934-9. PubMed ID: 12192085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.
    Chavkin C; Sud S; Jin W; Stewart J; Zjawiony JK; Siebert DJ; Toth BA; Hufeisen SJ; Roth BL
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1197-203. PubMed ID: 14718611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse.
    Fantegrossi WE; Kugle KM; Valdes LJ; Koreeda M; Woods JH
    Behav Pharmacol; 2005 Dec; 16(8):627-33. PubMed ID: 16286814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro pharmacological studies of new C(2) modified salvinorin A analogues.
    Lee DY; Karnati VV; He M; Liu-Chen LY; Kondaveti L; Ma Z; Wang Y; Chen Y; Beguin C; Carlezon WA; Cohen B
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3744-7. PubMed ID: 15993589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist.
    Munro TA; Rizzacasa MA; Roth BL; Toth BA; Yan F
    J Med Chem; 2005 Jan; 48(2):345-8. PubMed ID: 15658846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro pharmacological studies of C(4) modified salvinorin A analogues.
    Lee DY; He M; Kondaveti L; Liu-Chen LY; Ma Z; Wang Y; Chen Y; Li JG; Beguin C; Carlezon WA; Cohen B
    Bioorg Med Chem Lett; 2005 Oct; 15(19):4169-73. PubMed ID: 16051487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics.
    Cruz A; Domingos S; Gallardo E; Martinho A
    Phytochemistry; 2017 May; 137():9-14. PubMed ID: 28190678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the molecular mechanisms by which the diterpenoid salvinorin A binds to kappa-opioid receptors.
    Yan F; Mosier PD; Westkaemper RB; Stewart J; Zjawiony JK; Vortherms TA; Sheffler DJ; Roth BL
    Biochemistry; 2005 Jun; 44(24):8643-51. PubMed ID: 15952771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semisynthesis and Kappa-Opioid Receptor Activity of Derivatives of Columbin, a Furanolactone Diterpene.
    Yilmaz A; Crowley RS; Sherwood AM; Prisinzano TE
    J Nat Prod; 2017 Jul; 80(7):2094-2100. PubMed ID: 28718638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys.
    Butelman ER; Harris TJ; Kreek MJ
    Psychopharmacology (Berl); 2004 Mar; 172(2):220-4. PubMed ID: 14586540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands.
    Harding WW; Tidgewell K; Byrd N; Cobb H; Dersch CM; Butelman ER; Rothman RB; Prisinzano TE
    J Med Chem; 2005 Jul; 48(15):4765-71. PubMed ID: 16033256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioisosteric modification of salvinorin A, a potent and selective kappa-opioid receptor agonist.
    Stewart DJ; Fahmy H; Roth BL; Yan F; Zjawiony JK
    Arzneimittelforschung; 2006; 56(4):269-75. PubMed ID: 16724512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive and hypothermic effects of Salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout mice.
    Ansonoff MA; Zhang J; Czyzyk T; Rothman RB; Stewart J; Xu H; Zjwiony J; Siebert DJ; Yang F; Roth BL; Pintar JE
    J Pharmacol Exp Ther; 2006 Aug; 318(2):641-8. PubMed ID: 16672569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro pharmacological studies of new C(4)-modified salvinorin A analogues.
    Lee DY; He M; Liu-Chen LY; Wang Y; Li JG; Xu W; Ma Z; Carlezon WA; Cohen B
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5498-502. PubMed ID: 16945525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of salvinorin A, a kappa-opioid hallucinogen, on a neuroendocrine biomarker assay in nonhuman primates with high kappa-receptor homology to humans.
    Butelman ER; Mandau M; Tidgewell K; Prisinzano TE; Yuferov V; Kreek MJ
    J Pharmacol Exp Ther; 2007 Jan; 320(1):300-6. PubMed ID: 17060493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hallucinogen derived from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in rats.
    Willmore-Fordham CB; Krall DM; McCurdy CR; Kinder DH
    Neuropharmacology; 2007 Sep; 53(4):481-6. PubMed ID: 17681558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of 2-alkyl-2-methoxymethyl-salvinorin ethers as selective κ-opioid receptor agonists.
    Lee DY; Deng G; Ma Z; Xu W; Yang L; Liu J; Dai R; Liu-Chen LY
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4689-92. PubMed ID: 26330078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-methylacetamide analog of salvinorin A: a highly potent and selective kappa-opioid receptor agonist with oral efficacy.
    Béguin C; Potter DN; Dinieri JA; Munro TA; Richards MR; Paine TA; Berry L; Zhao Z; Roth BL; Xu W; Liu-Chen LY; Carlezon WA; Cohen BM
    J Pharmacol Exp Ther; 2008 Jan; 324(1):188-95. PubMed ID: 17951511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.